Prosight Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Prosight Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,000	Closed	-$1.38M	–	54
2020 Q4	$1.38M	Buy	+18,000	New	+$1.35M	0.64%	32
2020 Q1	–	Sell	-142,400	Closed	-$6.47M	–	53
2019 Q4	$6.47M	Buy	+142,400	New	+$6.73M	2.84%	15

Prosight Management's ARNA Position: Q1 2022 in Review

Prosight Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 45,000 shares — an estimated $4.18M sold.

Prosight Management first reported a position in ARNA in Q1 2018 and held it in 16 quarters. The position peaked at $17.6M in Q1 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Prosight Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Prosight Management sold 45,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.18M.
Prosight Management first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 16 quarters.
Prosight Management's Arena Pharmaceuticals Inc position peaked at $17.6M in Q1 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Prosight Management's 13F filing for Q1 2022, filed 16 May 2022.